Tag: cannabis
The Latest in Independent Testing: Part 2
Continuing our talk with Elan M. Sudberg, CEO, Alkemist Labs, and Jesse Miller, Ph.D., Director, NSF International Applied Research Center, we take a closer...
“The Father of Cannabis Research” to be Honored
San Fransisco, CA-- “The Father of Cannabis Research" Raphael Mechoulam will be honored with a Lifetime Achievement Award and a $10,000 research grant from The...
FTC Warns More CBD Companies Over Health Claims
Washington, D.C.--The Federal Trade Commission announced that, as part of its regular monitoring of health-related advertising claims, it sent warning letters to three companies...
Hemp Crops in Hawaii Destroyed
Hawaii—More than half the hemp crops cultivated in Hawaii this past year had to be destroyed due to high THC levels, according to Hawaii...
Big Pharma, the Opioid Crisis, and Natural Pain Relief
Oklahoma—Judge Thad Balkman of Cleveland County District Court ruled on Monday that Johnson & Johnson (J&J) had intentionally downplayed the risks and oversold the...
Industry Reacts to Gottlieb’s Op-Ed: Agree With His Urgency, Disagree With His Methods
Washington, D.C.—Scott Gottlieb, M.D., resident fellow at the American Enterprise Institute and former commissioner of FDA, wrote an op-ed in The Washington Post calling...
U.S. Cannabis Market Projected to Hit $40 Billion by 2025
The U.S. cannabis market could more than quadruple by 2025, according a new report from The Nielsen Company titled "Brace for Impact: U.S. CPG...
Courts in Italy, Sweden Rule on THC-Containing Products
Italy, Sweden--CBD is broadly legal across Europe, according to a report by Fortune. The Brightfield Group, a market intelligence firm for the legal cannabidiol...
Alkemist and Nutrasource Announce THC Compliance Testing Certification Program
Garden Grove, CA--Alkemist Labs announced in a press release that it was teaming up with Nutrasource, a Canadian contract research organization, to launch the...
FDA Cannabis/CBD Public Hearing: “FDA Does Not Have the Luxury Of Time”
Washington, D.C.—The Food and Drug Administration (FDA) held a public hearing on Friday looking for scientific data and information regarding cannabis and cannabis-derived compounds....
